STUDY SHOWS CHROMEMATE® INCREASES LIFESPAN - Average Lifespan of Test Animals Increased by More than 20 Percent

BENICIA, Calif., November 30, 2005 – ChromeMate®, InterHealth Nutraceuticals’ patented oxygen-coordinated, niacin-bound chromium ingredient, demonstrated its ability to prolong the life span of test animals by more than 20 percent. The study, conducted by researchers at Georgetown University Medical Center (Washington, DC) and Creighton University Medical Center (Omaha, NE), was presented at the 46th Annual Meeting of the American College of Nutrition, September 22-25, 2005, in Kiawah Island, South Carolina.

In the study, rats prone to many of the manifestations of aging were fed diets containing ChromeMate, which increased their average life span by 22 percent compared to rats fed the same diet without ChromeMate. Rats fed ChromeMate also experienced lower systolic blood pressure, lower circulating glucose levels, and a trend toward lower, normalized hemoglobin levels, a long-term indicator of blood sugar status. There were no abnormalities in blood chemistry, kidney or liver function in any group.

The first death in the ChromeMate group did not occur until week 59, while the first death in the control (placebo) group occurred at week 47. Thirty three percent of the animals in the ChromeMate group lived at least one month beyond the last animal in the control group.

“We’ve long known that niacin-bound chromium provides significant health benefits relative to metabolic syndrome,” stated lead researcher, Harry G. Preuss, M.D. from Georgetown University Medical Center. “These new results open the possibility that ChromeMate niacin-bound chromium may prolong human life as well.”

Generically known as chromium nicotinate or chromium polynicotinate, ChromeMate is a unique oxygen-coordinated niacin-bound chromium complex that plays an important role in proper insulin function, maintenance of healthy blood sugar and normal cholesterol levels, normal energy production, and promotion of healthy body weight. ChromeMate is protected by three U.S. patents, four international patents and other worldwide patents pending, and is the only niacin-bound chromium supplement with proven biological activity. Earlier this year, ChromeMate received GRAS status (Generally Recognized as Safe) for use in functional beverages.

A product of InterHealth Nutraceuticals Inc., ChromeMate® is a value-added dietary ingredient available to manufacturers for use in dietary supplements and nutraceutical food and beverage products. InterHealth researches, develops, manufactures, markets and distributes specialty nutritional ingredients, which are sold to manufacturers worldwide. In addition to ChromeMate®, InterHealth makes Super CitriMax®, OptiBerry®, Aller-7®, UC-II®, Protykin® and L-OptiZinc®. For more information about the company and its products, call 1-800-783-4636 or 1-707-751-2800 (outside U.S.) or visit its website at www.InterHealthUSA.com

Note: Statements made in this release have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Research data is available upon request.